Upregulation of GLUT1 has been found in the hypoxic regions of the human colon and breast tumors, while inhibition of GLUT1 by phloretin sensitizes cancer cells to daunorubicin-induced cytotoxicity and overcomes drug resistance under hypoxia (Cao et al., 2007). This evidence concerns the gene SLC2A1 and breast neoplasm.